Clinical trials
Leukemia trials in France with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 8 |
| Assistance Publique Hopitaux De Marseille | 4 |
| Antisoma Research | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Dutch Childhood Oncology Group | 1 |
| Facet Biotech | 1 |
| Glycostem Therapeutics BV | 1 |
| Institut Paoli-Calmettes | 1 |
| Institut de Recherche Clinique sur les Cancers et le Sang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 24 |
| Leukemia, Myeloid, Acute | 9 |
| Leukemia, Monocytic, Acute | 6 |
| Leukemia, Myelomonocytic, Acute | 6 |
| Leukemia, Erythroblastic, Acute | 5 |
| Leukemia, Megakaryoblastic, Acute | 5 |
| Lymphoma | 5 |
| Congenital Abnormalities | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.